Global Type 2 Diabetes Market is segmented By Drug Type (Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists), Sodium-glucose Transporter 2 (SGLT2) Inhibitors, Meglitinides, Sulfonylureas, Thiazolidinediones, Biguanides (Metformin), Bile Acid sequestrants (Colesevelam), Amylin Mimetics (Pramlintide)), By Gender (Male, Female), By Age Group (Up to 19 years, 20 – 65 years, Above 65 years), By Route of Administration (Oral, Parenteral), By Application (Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Others), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
$4350
$4350
$4350
$4350
$4350
$4350